International Companies

Moderna impresses with smaller Q4 loss, 2026 growth targets

By Benjamin Chiou

Date: Friday 13 Feb 2026

(Sharecast News) - Moderna revenues fell by almost a third over the final quarter of 2025, though the American pharma giant reported a narrower loss than expected, causing shares to rise in pre-market trading.
Revenues totalled $678m over the three months to 31 December, down 31% from the year before slightly...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page